Crossmark

Familial acute myeloid leukemia due to a novel germline CEBPA pathogenic variant – a case report

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.07.004

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gava, Flavia https://orcid.org/0000-0001-5888-6666
Catto, Luiz Fernando Bazzo https://orcid.org/0000-0002-4019-3850
Valera, Elvis https://orcid.org/0000-0002-4434-429X
Francisco dos Reis, Maristella Bergamo https://orcid.org/0000-0002-5809-0972
Pintão, Maria Carolina Tostes https://orcid.org/0000-0002-6452-7931
Chauffaille, Maria de Lourdes https://orcid.org/0000-0003-0589-3795
Ramos, Flavia Sacilotto Donaires https://orcid.org/0000-0001-9996-1298
Scrideli, Carlos Alberto https://orcid.org/0000-0001-6618-789X
Pontes, Lorena Lobo Figueiredo https://orcid.org/0000-0002-2139-5756
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-09-04
More Information

This article is maintained by: Elsevier

Article Title: Familial acute myeloid leukemia due to a novel germline CEBPA pathogenic variant – a case report

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.07.004

Content Type: article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.